Samsung Electronics and Massachusetts Basic Hospital (MGH) Diabetes Analysis Heart (DRC) at this time collectively introduced a analysis examine to analyze the efficacy of Galaxy Watch in helping adults beginning GLP-1RA1 remedy to observe and probably handle muscle loss. With almost one in 5 adults within the US saying they’ve taken GLP-1 medicine, this modern medical examine will examine how steady knowledge from Galaxy Watch will help sufferers and clinicians monitor and mitigate muscle loss by offering a clearer, extra holistic view of an individual’s physique composition and exercise ranges throughout therapy.
As GLP-1 medicines turn out to be broadly adopted for weight administration and persistent illness therapy, monitoring adjustments in muscle mass and bodily exercise alongside weight reduction has emerged as a key medical focus. This analysis will delve into the feasibility of managing muscle loss for GLP-1 sufferers by using biometric knowledge together with physique composition, exercise ranges and coronary heart fee offered by Galaxy Watch and Samsung Well being.
Samsung and MGH have constantly collaborated on digital well being analysis using each Galaxy Watch and Samsung Well being, together with research on Superior Glycation Finish Merchandise (AGEs). The MGH Diabetes Analysis Heart, which makes a speciality of analysis on diabetes and GLP-1 weight problems therapy, initiated the joint examine with Samsung after recognizing the potential for wearables to observe physique composition.
This examine will even make the most of Galaxy Watch8, powered by Samsung’s groundbreaking BioActive Sensor,2 which helps present superior predictive and preventative wellness via extra correct well being measurements.
Underneath the management of Dr. Melissa Putman, the examine will enroll 100 adults starting therapy with weight-loss medicines into two teams. The intervention group will use Galaxy Watch to observe their physique composition by way of Bioelectrical Impedance Evaluation (BIA), monitor bodily exercise and obtain customized train guides. Their progress might be in comparison with the opposite group, which can obtain the usual steering and care usually given to sufferers beginning GLP-1RA remedy.
To guage the examine’s progress, researchers will use clinical-grade DXA scans3 — the gold normal for physique composition evaluation — to trace physiological adjustments in each teams. These knowledge will assist decide whether or not the insights and tailor-made steering offered by Galaxy Watch8 can successfully assist members in constructing more healthy every day habits, which can in flip contribute to higher well being outcomes significantly in preserving muscle mass.
“Many GLP-1 sufferers wrestle with muscle mass loss, a standard aspect impact that may trigger an elevated threat of heart problems and a drop in basal metabolic fee, which may result in future weight regain,” stated Dr. Putman, Director of the MGH Diabetes Analysis Heart. “We’re interested by exploring how steady knowledge from a wearable machine can present invaluable insights right into a affected person’s exercise ranges, coronary heart fee and physique composition, giving clinicians a extra holistic view of therapy influence and permitting for extra well timed, data-driven changes to their care plan.”
“This collaboration with MGH focuses on addressing real-world well being challenges that sufferers face throughout GLP-1RA remedy, particularly managing muscle loss and constructing wholesome habits,” stated Jongmin Choi, Head of Well being R&D Group, Cell eXperience (MX) Enterprise, Samsung Electronics. “Finally, this examine highlights Samsung’s ongoing dedication to delivering complete and proactive well being administration options via the superior capabilities of Galaxy Watch.”
Samsung stays dedicated to researching how Galaxy Watch can assist sufferers in managing their every day bodily well being. By fostering sustainable wellness habits, the corporate goals to assist sufferers obtain higher medical outcomes and long-term vitality.
Samsung continues to broaden its partnerships with main medical establishments to advance wearable well being monitoring capabilities and broaden the digital well being ecosystem. Just lately, Samsung demonstrated the potential for early vasovagal syncope (VVS) detection utilizing Galaxy Watch in a joint medical examine with Chung-Ang College Gwangmyeong Hospital in Korea and likewise collaborated with Stanford Drugs to additional advance Galaxy Watch’s Sleep Apnea function.
